Beyond Competitive Advantage – Who should be trusted to distribute a product requiring a REMS?

By |2019-09-22T03:57:51+00:00July 2nd, 2015|

Beyond Competitive Advantage - Who should be trusted to distribute a product requiring a REMS? As discussed in the New England Journal of Medicine on April 17, 2014 by Sarpatwari, Avorn, and Kesselheim, REMS are being used as a source of competitive advantage by some pharmaceutical companies. Researchers from the Brigham and Women's Hospital [...]